Health, Fitness & Food

In this article PFE MRNA A child is administered a dose of the Pfizer-BioNTech coronavirus disease (COVID-19) pediatric vaccine. Mayela Lopez | Reuters The Centers for Disease Control and Prevention’s independent vaccine experts on Saturday backed Pfizer’s and Moderna’s Covid-19 shots for children as young as 6 months. The CDC committee voted unanimously to recommend
0 Comments
In this article MRNA PFE The Food and Drug Administration on Friday authorized Moderna‘s and Pfizer‘s Covid-19 shots for children as young as 6 months old, which makes nearly every person in the U.S. now eligible for vaccination. The FDA decision comes after its committee of independent vaccine experts voted unanimously to recommend the shots
0 Comments
Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, attends a Senate Health, Education, Labor, and Pensions Committee hearing to examine the federal response to the coronavirus disease (COVID-19) and new emerging variants at Capitol Hill in Washington, D.C., U.S. January 11, 2022. Greg Nash | Reuters Dr. Anthony Fauci, the
0 Comments
A kindergarten student gives the thumbs up to her teacher before starting the first day of kindergarten at Laguna Niguel Elementary School in Laguna Niguel, CA on Tuesday, August 17, 2021. Paul Bersebach | MediaNews Group | Getty Images Moderna and Pfizer’s Covid-19 vaccines for infants through preschoolers have moved a step closer to authorization
0 Comments
A young man receives his Covid-19 vaccination at a vaccination clinic. People receive the Moderna vaccine in Milford, Pennsylvania. Preston Ehrler | LightRocket | Getty Images Moderna’s two-dose Covid-19 vaccine for kids ages 6 through 17 received the endorsement from the Food and Drug Administration’s committee of independent immunization experts on Tuesday, a key step
0 Comments
We’re buying 50 shares of Johnson & Johnson (JNJ) at roughly $171.51 each. Following Monday’s trade, the portfolio will own 250 shares of JNJ, increasing its weighting to 1.55% from 1.22%. The broader markets are selling off hard Monday as concerns about inflation, rising interest rates, and a wipeout of value in cryptocurrencies have investors
0 Comments
Novavax’s two-dose Covid-19 vaccine for adults ages 18 and older cleared a key step on the path toward Food and Drug Administration authorization on Tuesday. The FDA’s committee of independent vaccine experts voted 21 to 0 with one abstention at the end of an all-day meeting to recommend authorizing the shot for use in the
0 Comments
A man checks in at a Covid-19 testing site in the international arrivals area of Los Angeles International Airport in Los Angeles, California on December 22, 2021. Frederic J. Brown | AFP | Getty Images Travel and hospitality CEOs are stepping up pressure on the Biden administration to scrap a requirement that anyone flying into
0 Comments
A health worker prepares a dose of the Novavax vaccine as the Dutch Health Service Organization starts with the Novavax vaccination program on March 21, 2022 in The Hague, Netherlands. Patrick Van Katwijk | Getty Images The Food and Drug Administration needs to review changes to Novavax’s manufacturing process before it can authorize the biotech
0 Comments
Bausch + Lomb (BLCO) reported largely in-line fiscal first-quarter financial results before the opening bell Wednesday. The numbers were not a surprise because B+L reported its first quarter results inside of Bausch Health Companies ‘ (BHC) release in early May. However, Wednesday was still an important event because it marked the first time since its
0 Comments
Chiquita Brooks-LaSure testifies before the Senate Finance Committee during her nomination hearing to be administrator of the Centers for Medicare & Medicaid Services in Washington on Thursday, April 15, 2021. Caroline Brehman | CQ-Roll Call, Inc. | Getty Images In her first year as administrator of the Centers for Medicare and Medicaid Services, Chiquita Brooks-Lasure
0 Comments
In this photo illustration the Food and Drug Administration (FDA) and Novavax logos are seen behind a medical syringe and vials. Pavlo Gonchar | LightRocket | Getty Images Novavax’s Covid-19 vaccine will face the scrutiny of the Food and Drug Administration’s independent immunization experts this week, a crucial step on the path toward U.S. regulatory
0 Comments